Evidence map›Paper›PMID 40108729›Full record

ArticleDiabetology & metabolic syndrome2025

Identification of variants in exon 4 of the LDLR gene and assessment of their effects on the produced proteins in saudi women with metabolic syndrome.

Hiba S Al-Amodi, Nazik Altayeb Abdelbasit, Sameer H Fatani, Mohiuddin M Taher, Maowia Mohamed Mukhtar, Ayman S Mohamed, Abdallah M Gameel, Hala F M Kamel, Shimaa Abdelsattar

Abstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hiba S Al-AmodiDepartment of Biochemistry, Faculty of Medicine, Umm ALQura University, 21955, Makka, Saudi Arabia.
Nazik Altayeb AbdelbasitDepartment of Medical Biochemistry, Faculty of Medicine, National University Khartoum, Khartoum, 11115, Sudan.
Sameer H FataniDepartment of Biochemistry, Faculty of Medicine, Umm ALQura University, 21955, Makka, Saudi Arabia.
Mohiuddin M TaherScience and Technology Unit and the Department of Medical Genetics, Umm Al-Qura University, 21955, Makkah, Saudi Arabia.
Maowia Mohamed MukhtarInstitute of Endemic Diseases, University of Khartoum, Medical Campus, Khartoum, Khartoum, 11115, Sudan.
Ayman S MohamedMolecular Biologist, Children Cancer Hospital Egypt, Cairo, 57357, Egypt.
Abdallah M GameelClinical Pathology Department, National Cancer Institute, Cairo University, Cairo, 11796, Egypt.
Hala F M KamelDepartment of Biochemistry, Faculty of Medicine, Umm ALQura University, 21955, Makka, Saudi Arabia.
Shimaa AbdelsattarClinical Biochemistry and Molecular Diagnostics Department, National Liver Institute, Menoufia University, Menoufia, Egypt. Shimaa.abdelsattar@liver.menofia.edu.eg.

Funding

This study was supported by a grant from The Deanship of Scientific Research (DSR) Umm-Al-Qura University, Makkah to Dr. Sameer H. Fatani . (Code number- 4340109635)
6 · The paper itself

Abstract

backgroundGenetic factors might influence metabolic syndrome (MetS) or any of its components. It was postulated that low density lipoprotein receptor (LDLR) gene variants could play a role in cholesterol hemostasis and the development of MetS. However, the causal-effect relationship between such variants and the development of MetS is not clearly identified or even studied before in Saudi Arabian women. This study aims to identify the variants of LDLR exon-4 in Saudi Arabian women with MetS in comparison to healthy women and to assess the expected effect of amino acids alterations on the structure and functions of the LDLR proteins. A total of 208 female Saudi patients with MetS and 104 controls were included in the study. The exon 4 of LDLR gene was studied by DNA sequencing (Sanger) and structural analysis was performed using Project HOPE software.

resultsFour variants were identified; 2 were missense variants (2.4%; 5/208): (p.D172N and p.D178N) and 2 were nonsense variants (stop gained) (1.44%; 3/208): (p.E140* and p.L135*). Structural analysis of the expected effects of such variants revealed that they might disrupt their interactions with other proteins or biomolecules, additionally, the nonsense variants via expressing a stop codon, these will produce a truncated protein resulting in a defective function of LDL receptor.

conclusionsFour variants in the LDLR gene, exon 4 (2 missense and 2 nonsense variants) have been identified and their expected structural effects were assessed in Saudi Arabian women with MetS in Makkah region.

Indexed as

DNA sequencingLDLR gene exon 4LDLR proteinsMetabolic syndromeSaudi women

Identifiers

PMID40108729
PMCPMC11921633

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.